Browse by UCL Departments and Centres
 | Up a level |
Group by: Author | Type
Number of items: 362.
A
Aaboud, M;
Aad, G;
Abbott, B;
Abdinov, O;
Abeloos, B;
Abhayasinghe, DK;
Abidi, SH;
... Zwalinski, L; + view all
(2019)
Searches for scalar leptoquarks and differential cross-section measurements in dilepton-dijet events in proton-proton collisions at a centre-of-mass energy of root s=13TeV with the ATLAS experiment.
The European Physical Journal C
, 79
, Article 733. 10.1140/epjc/s10052-019-7181-x.
|
 |
|
Abeti, R;
Baccaro, A;
Giunti, P;
(2019)
Mitochondrial Dysfunction in Friedreich Ataxia.
In: Ahmad, SI, (ed.)
Handbook of Mitochondrial Dysfunction.
CRC Press: Boca Raton, FL, USA.
|
|
Adeleke, S;
Latifoltojar, A;
Sidhu, H;
Galazi, M;
Shah, TT;
Clemente, J;
Davda, R;
... Punwani, S; + view all
(2019)
Localising occult prostate cancer metastasis with advanced imaging techniques (LOCATE trial): a prospective cohort, observational diagnostic accuracy trial investigating whole-body magnetic resonance imaging in radio-recurrent prostate cancer.
BMC Medical Imaging
, 19
, Article 90. 10.1186/s12880-019-0380-y.
|
|
|
Agostinelli, C;
Akarca, AU;
Ramsay, A;
Rizvi, H;
Rodriguez-Justo, M;
Pomplun, S;
Proctor, I;
... Marafioti, T; + view all
(2019)
Novel markers in pediatric-type follicular lymphoma.
Virchows Archiv
10.1007/s00428-019-02681-y.
(In press).
|
|
|
Ahmad, SS;
Crittenden, MR;
Tran, PT;
Kluetz, PG;
Blumenthal, GM;
Bulbeck, H;
Baird, RD;
... Sharma, RA; + view all
(2019)
Clinical Development of Novel Drug–Radiotherapy Combinations.
Clinical Cancer Research
, 25
(5)
pp. 1455-1461.
10.1158/1078-0432.CCR-18-2466.
|
|
Ahmedzai, SH;
Snowden, JA;
Ashcroft, AJ;
Cairns, DA;
Williams, C;
Hockaday, A;
Cavenagh, JD;
... Cook, G; + view all
(2019)
Patient-Reported Outcome Results From the Open-Label, Randomized Phase III Myeloma X Trial Evaluating Salvage Autologous Stem-Cell Transplantation in Relapsed Multiple Myeloma.
Journal of Clinical Oncology
, 37
(19)
pp. 1617-1628.
10.1200/jco.18.01006.
|
|
|
Akintonde, A;
Grimes, H;
Moinuddin, S;
Sharma, RA;
McClelland, J;
Thielemans, K;
(2019)
EP-2067 Data driven region of interest respiratory surrogate signal extraction from CBCT data.
Presented at: 38th Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), Milan, Italy.
|
|
Akintonde, A;
Thielemans, K;
Sharma, R;
Mouches, P;
Mory, C;
Rit, S;
McClelland, J;
(2019)
Respiratory motion model derived from CBCT projection data.
In:
Proceedings of the 19th International Conference on the Use of Computers in Radiation Therapy.
ICCR
(In press).
|
|
Alzoubaidi, D;
Graham, D;
Bassett, P;
Magee, C;
Everson, M;
Banks, M;
Novelli, M;
... Haidry, R; + view all
(2019)
Comparison of two multiband mucosectomy devices for endoscopic resection of Barrett's esophagus-related neoplasia.
Surgical Endoscopy
10.1007/s00464-018-06655-0.
(In press).
|
|
|
Alzoubaidi, D;
Ragunath, K;
Wani, S;
Penman, ID;
Trudgill, NJ;
Jansen, M;
Banks, M;
... Haidry, R; + view all
(2019)
Quality indicators for Barrett's endotherapy (QBET): UK consensus statements for patients undergoing endoscopic therapy for Barrett's neoplasia.
Frontline Gastroenterology
10.1136/flgastro-2019-101247.
|
|
|
Amary, F;
Markert, E;
Berisha, F;
Ye, H;
Gerrand, C;
Cool, P;
Tirabosco, R;
... Flanagan, AM; + view all
(2019)
FOS Expression in Osteoid Osteoma and Osteoblastoma: A Valuable Ancillary Diagnostic Tool.
American Journal of Surgical Pathology
10.1097/PAS.0000000000001355.
(In press).
|
|
Amary, F;
Perez-Casanova, L;
Ye, H;
Cottone, L;
Strobl, A-C;
Cool, P;
Miranda, E;
... Flanagan, AM; + view all
(2019)
Synovial chondromatosis and soft tissue chondroma: extraosseous cartilaginous tumor defined by FN1 gene rearrangement.
Modern Pathology
10.1038/s41379-019-0315-8.
(In press).
|
|
Anandagoda, N;
Willis, JC;
Hertweck, A;
Roberts, LB;
Jackson, I;
Gökmen, MR;
Jenner, RG;
... Lord, GM; + view all
(2019)
microRNA-142-mediated repression of phosphodiesterase 3B critically regulates peripheral immune tolerance.
Journal of Clinical Investigation
10.1172/JCI124725.
(In press).
|
|
|
Ankcorn, MJ;
Fox, TA;
Ijaz, S;
Nicholas, C;
Houston, E;
Longair, I;
Suri, D;
... Sekhar, M; + view all
(2019)
Characterising the risk of Hepatitis E virus infection in haematological malignancies: a UK prospective prevalence study.
British Journal of Haematology
10.1111/bjh.15796.
(In press).
|
|
Antas, P;
Novellasdemunt, L;
Kucharska, A;
Massie, I;
Carvalho, J;
Oukrif, D;
Nye, E;
... Li, VSW; + view all
(2019)
SH3BP4 Regulates Intestinal Stem Cells and Tumorigenesis by Modulating β-Catenin Nuclear Localization.
Cell Reports
, 26
(9)
2266-2273.e4.
10.1016/j.celrep.2019.01.110.
|
|
|
Armenteros-Monterroso, E;
Zhao, L;
Gasparoli, L;
Brooks, T;
Pearce, K;
Mansour, MR;
Martens, JHA;
... Williams, O; + view all
(2019)
The AAA+ATPase RUVBL2 is essential for the oncogenic function of c-MYB in acute myeloid leukemia.
Leukemia
, 33
pp. 2817-2829.
10.1038/s41375-019-0495-8.
|
|
Aswendt, M;
Vogel, S;
Schaefer, C;
Jathoul, A;
Pule, M;
Hoehn, M;
(2019)
Quantitative in vivo dual-color bioluminescence imaging in the mouse brain.
Neurophotonics
, 6
(2)
, Article 025006. 10.1117/1.NPh.6.2.025006.
|
|
|
Attard, G;
Conteduca, V;
Wetterskog, D;
(2019)
A multimodal approach to outcome prediction in metastatic castration-resistant prostate cancer by integrating functional imaging and plasma DNA analysis.
JCO Precision Oncology
10.1200/PO.18.00302.
(In press).
|
|
Attard, G;
Jayaram, A;
Wingate, A;
Wetterskog, K;
(2019)
Plasma androgen receptor copy number status at emergence of metastatic castration-resistant prostate cancer: a pooled multi-cohort analysis.
JCO Precision Oncology
10.1200/PO.19.00123.
(In press).
|
|
Attard, G;
Wetterskog, D;
Jayaram, A;
Wingate, A;
(2019)
Plasma AR status and cabazitaxel in heavily-treated metastatic castration-resistant prostate cancer.
European Journal of Cancer
, 116
pp. 158-168.
10.1016/j.ejca.2019.05.007.
|
|
Avenali, M;
Toffoli, M;
Mullin, S;
McNeil, A;
Hughes, DA;
Mehta, A;
Blandini, F;
(2019)
Evolution of prodromal parkinsonian features in a cohort of GBA mutation-positive individuals: a 6-year longitudinal study.
Journal of Neurology, Neurosurgery & Psychiatry
10.1136/jnnp-2019-320394.
(In press).
|
B
|
Bailey, C;
Bourne, RM;
Siow, B;
Johnston, EW;
Brizmohun Appayya, M;
Pye, H;
Heavey, S;
... Panagiotaki, E; + view all
(2019)
VERDICT MRI validation in fresh and fixed prostate specimens using patient-specific moulds for histological and MR alignment.
NMR in Biomedicine
, Article e4073. 10.1002/nbm.4073.
(In press).
|
|
|
Bailey, Katharine Elizabeth;
(2019)
CD20 as a prognostic biomarker and as a potential therapeutic target of oncolytic measles virus in adult acute lymphoblastic leukaemia.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Baker, A-M;
Gabbutt, C;
Williams, MJ;
Cereser, B;
Jawad, N;
Rodriguez-Justo, M;
Jansen, M;
... Wright, NA; + view all
(2019)
Crypt fusion as a homeostatic mechanism in the human colon.
Gut
10.1136/gutjnl-2018-317540.
(In press).
|
|
|
Banerjee, G;
Chan, E;
Ambler, G;
Wilson, D;
Cipolotti, L;
Shakeshaft, C;
Cohen, H;
... Vahidassr, D; + view all
(2019)
Effect of small-vessel disease on cognitive trajectory after atrial fibrillation-related ischaemic stroke or TIA.
Journal of Neurology
, 266
(5)
pp. 1250-1259.
10.1007/s00415-019-09256-6.
|
|
|
Banks, M;
Graham, D;
Jansen, M;
Gotoda, T;
Coda, S;
di Pietro, M;
Uedo, N;
... Dinis-Ribeiro, M; + view all
(2019)
British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma.
Gut
10.1136/gutjnl-2018-318126.
(In press).
|
|
|
Barber, PR;
Weitsman, G;
Lawler, K;
Barrett, J;
Rowley, M;
Rodriguez-Justo, M;
Fisher, D;
... Ng, T; + view all
(2019)
HER2-HER3 heterodimer quantification by FRET-FLIM and patient subclass analysis of the COIN colorectal trial.
JNCI: Journal of the National Cancer Institute
10.1093/jnci/djz231.
(In press).
|
|
|
Barrington, C;
Georgopoulou, D;
Pezic, D;
Varsally, W;
Herrero, J;
Hadjur, S;
(2019)
Enhancer accessibility and CTCF occupancy underlie asymmetric TAD architecture and cell type specific genome topology.
Nature Communications
, 10
, Article 2908. 10.1038/s41467-019-10725-9.
|
|
|
Barrington, SF;
Phillips, EH;
Counsell, N;
Hancock, B;
Pettengell, R;
Johnson, P;
Townsend, W;
... Radford, J; + view all
(2019)
Positron Emission Tomography Score Has Greater Prognostic Significance Than Pretreatment Risk Stratification in Early-Stage Hodgkin Lymphoma in the UK RAPID Study.
Journal of Clinical Oncology
, 37
(20)
pp. 1732-1741.
10.1200/JCO.18.01799.
|
|
|
Barrington, SF;
Phillips, EH;
Counsell, N;
Radford, J;
(2019)
Reply to H.J.A. Adams et al and C. Kobe et al.
Journal of Clinical Oncology
, 37
(34)
pp. 3325-3326.
10.1200/JCO.19.02056.
|
|
Barton, J;
Pacey, K;
Jain, N;
Kasia, T;
Edwards, D;
Thevanesan, C;
Straathof, K;
... Anderson, J; + view all
(2019)
Establishment and phenotyping of neurosphere cultures from primary neuroblastoma samples.
F1000Research
, 8
, Article 823. 10.12688/f1000research.18209.1.
|
|
|
Baumhoer, D;
Amary, F;
Flanagan, AM;
(2019)
An update of molecular pathology of bone tumors. Lessons learned from investigating samples by next generation sequencing.
Genes, Chromosomes and Cancer
, 58
(2)
pp. 88-99.
10.1002/gcc.22699.
|
|
Baumhoer, D;
Kovac, M;
Sperveslage, J;
Ameline, B;
Strobl, A-C;
Krause, A;
Trautmann, M;
... Hartmann, W; + view all
(2019)
Activating mutations in the MAP-kinase pathway define non-ossifying fibroma of bone.
The Journal of Pathology
10.1002/path.5216.
(In press).
|
|
Bazarbachi, A;
Boumendil, A;
Finel, H;
Mohty, M;
Castagna, L;
Blaise, D;
Peggs, KS;
... Sureda, A; + view all
(2019)
Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party.
Cancer
, 125
(1)
pp. 90-98.
10.1002/cncr.31755.
|
|
Beaton, L;
Bandula, S;
Gaze, MN;
Sharma, RA;
(2019)
How rapid advances in imaging are defining the future of precision radiation oncology.
British Journal of Cancer
, 120
pp. 779-790.
10.1038/s41416-019-0412-y.
|
|
Beaton, L;
Bergman, A;
Nichol, A;
Aparicio, M;
Wong, G;
Gondara, L;
Speers, C;
... Tyldesley, S; + view all
(2019)
Cardiac death after breast radiotherapy and the QUANTEC cardiac guidelines.
Clinical and Translational Radiation Oncology
, 19
pp. 39-45.
10.1016/j.ctro.2019.08.001.
|
|
|
Beaton, L;
Tregidgo, HFJ;
Znati, SA;
Forsyth, S;
Clarkson, MJ;
Bandula, S;
Chouhan, M;
... Sharma, RA; + view all
(2019)
VEROnA Protocol: A Pilot, Open-Label, Single-Arm, Phase 0, Window-of-Opportunity Study of Vandetanib-Eluting Radiopaque Embolic Beads (BTG-002814) in Patients With Resectable Liver Malignancies.
JMIR Research Protocols
, 8
(10)
, Article e13696. 10.2196/13696.
|
|
|
Beedham, W;
Peck, G;
Richardson, S;
Tsang, K;
Fertleman, M;
Shipway, D;
(2019)
Head injury in the elderly – an overview for the physician.
Clinical Medicine
, 19
(2)
pp. 177-184.
10.7861/clinmedicine.19-2-177.
|
|
Bell, CG;
Lowe, R;
Adams, PD;
Baccarelli, AA;
Beck, S;
Bell, JT;
Christensen, BC;
... Rakyan, VK; + view all
(2019)
DNA methylation aging clocks: challenges and recommendations.
Genome Biology
, 20
, Article 249. 10.1186/s13059-019-1824-y.
|
|
|
Beltran, M;
Tavares, M;
Justin, N;
Khandelwal, G;
Ambrose, J;
Foster, BM;
Worlock, KB;
... Jenner, RG; + view all
(2019)
G-tract RNA removes Polycomb repressive complex 2 from genes.
Nature Structural & Molecular Biology
10.1038/s41594-019-0293-z.
(In press).
|
|
Bennett, CL;
Ambler, CA;
(2019)
Editorial: Langerhans Cells and How Skin Pathology Reshapes the Local Immune Environment.
Frontiers in Immunology
, 10
, Article 139. 10.3389/fimmu.2019.00139.
|
|
|
Bentham, RB;
Bryson, K;
Szabadkai, G;
(2019)
Biclustering Analysis of Co-regulation Patterns in Nuclear-Encoded Mitochondrial Genes and Metabolic Pathways.
Cancer Metabolism
, 1928
pp. 469-478.
10.1007/978-1-4939-9027-6_24.
|
|
Bilanges, B;
Posor, Y;
Vanhaesebroeck, B;
(2019)
PI3K isoforms in cell signalling and vesicle trafficking.
Nature Reviews Molecular Cell Biology
, 20
pp. 515-534.
10.1038/s41580-019-0129-z.
|
|
Biswas, D;
Birkbak, NJ;
Rosenthal, R;
Hiley, CT;
Lim, EL;
Papp, K;
Boeing, S;
... TRACERx Consortium, ; + view all
(2019)
A clonal expression biomarker associates with lung cancer mortality.
Nature Medicine
, 25
pp. 1540-1548.
10.1038/s41591-019-0595-z.
|
|
Black, JR;
Goldin, RD;
Foxton, M;
Marafioti, T;
Akarca, AU;
Pria, AD;
Brock, C;
... Pinato, DJ; + view all
(2019)
PD-L1 expressing granulomatous reaction as an on-target mechanism of steroid-refractory immune hepatotoxicity.
Immunotherapy
, 11
(7)
pp. 585-590.
10.2217/imt-2018-0187.
|
|
Blackwood, DH;
Walker, D;
Mythen, MG;
Taylor, RM;
Vindrola-Padros, C;
(2019)
Barriers to advance care planning with patients as perceived by nurses and other healthcare professionals: A systematic review.
Journal of Clinical Nursing
10.1111/jocn.15049.
(In press).
|
|
Boire, A;
Coffelt, SB;
Quezada, SA;
Vander Heiden, MG;
Weeraratna, AT;
(2019)
Tumour Dormancy and Reawakening: Opportunities and Challenges.
Trends in Cancer
, 5
(12)
pp. 762-765.
10.1016/j.trecan.2019.10.010.
|
|
Boned Del Río, I;
Young, LC;
Sari, S;
Jones, GG;
Ringham-Terry, B;
Hartig, N;
Rejnowicz, E;
... Rodriguez-Viciana, P; + view all
(2019)
SHOC2 complex-driven RAF dimerization selectively contributes to ERK pathway dynamics.
Proceedings of the National Academy of Sciences of the United States of America
10.1073/pnas.1902658116.
(In press).
|
|
|
Boned del Río, Isabel;
(2019)
Therapeutic potential of SHOC2 via its selective contribution of the ERK pathway activation.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Breeze, CE;
Reynolds, AP;
van Dongen, J;
Dunham, I;
Lazar, J;
Neph, S;
Vierstra, J;
... Beck, S; + view all
(2019)
eFORGE v2.0: updated analysis of cell type-specific signal in epigenomic data.
Bioinformatics
10.1093/bioinformatics/btz456.
(In press).
|
|
|
Bridgewater, J;
(2019)
Systemic treatment of biliary tract cancer: now we have evidence.
Annals of Oncology
10.1093/annonc/mdz441.
(In press).
|
|
Brown, P;
Tan, A-C;
El-Esawi, MA;
Liehr, T;
Blanck, O;
Gladue, DP;
Almeida, GMF;
... Zhou, Y; + view all
(2019)
Large expert-curated database for benchmarking document similarity detection in biomedical literature search.
Database
10.1093/database/baz085.
(In press).
|
|
|
Bugeja, S;
Mistry, K;
Yim, IHW;
Tamimi, A;
Roberts, N;
Mundy, AR;
(2019)
A new Urethral Catheterisation Device (UCD) to manage Difficult Urethral Catheterisation.
World Journal of Urology
, 37
(4)
pp. 595-600.
10.1007/s00345-018-2499-9.
|
|
|
Burt, R;
Dey, A;
Aref, S;
Aguiar, M;
Akarca, A;
Bailey, K;
Day, W;
... Fielding, AK; + view all
(2019)
Activated Stromal Cells Transfer Mitochondria to Rescue Acute Lymphoblastic Leukaemia Cells from Oxidative Stress.
Blood
10.1182/blood.2019001398.
(In press).
|
|
Burt, R;
Warcel, D;
Fielding, AK;
(2019)
Blinatumomab, a bispecific B-cell and T-cell engaging antibody, in the treatment of B-cell malignancies.
Human Vaccines & Immunotherapeutics
, 15
(3)
pp. 594-602.
10.1080/21645515.2018.1540828.
|
|
Buzzetti, E;
Hall, A;
Ekstedt, M;
Manuguerra, R;
Guerrero Misas, M;
Covelli, C;
Leandro, G;
... Tsochatzis, EA; + view all
(2019)
Collagen proportionate area is an independent predictor of long-term outcome in patients with non-alcoholic fatty liver disease.
Alimentary Pharmacology and Therapeutics
10.1111/apt.15219.
(In press).
|
C
|
Calaminus, G;
Jenney, M;
Hjorth, L;
Baust, K;
Bernstein, M;
Bielack, S;
Vos, PD;
... Nagarajan, R; + view all
(2019)
Quality of Life of Patients With Osteosarcoma in the European American Osteosarcoma Study-1 (EURAMOS-1): Development and Implementation of a Questionnaire Substudy.
JMIR Research Protocols
, 8
(9)
, Article e14406. 10.2196/14406.
|
|
|
Cappellini, MD;
Porter, J;
Origa, R;
Forni, GL;
Voskaridou, E;
Galacteros, F;
Taher, AT;
... Hermine, O; + view all
(2019)
Sotatercept, a novel transforming growth factor beta ligand trap, improves anemia in beta-thalassemia: a phase II, open-label, dose-finding study.
Haematologica
, 104
(3)
pp. 477-484.
10.3324/haematol.2018.198887.
|
|
|
Carter, Thomas James;
(2019)
Magnetic Hyperthermia for the Treatment of Glioblastoma.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Carters, R;
Cheraghchi-Bashi, A;
Westhorpe, A;
Yu, S;
Shanneik, Y;
Seraia, E;
Ouaret, D;
... Sharma, RA; + view all
(2019)
Identification of anticancer drugs to radiosensitise BRAF-wild-type and mutant colorectal cancer.
Cancer Biology & Medicine
, 16
(2)
pp. 234-246.
10.20892/j.issn.2095-3941.2018.0284.
|
|
|
Castillo-Quan, JI;
Tain, LS;
Kinghorn, KJ;
Li, L;
Grönke, S;
Hinze, Y;
Blackwell, TK;
... Partridge, L; + view all
(2019)
A triple drug combination targeting components of the nutrient-sensing network maximizes longevity.
Proceedings of the National Academy of Sciences of the United States of America
, 116
(42)
pp. 20817-20819.
10.1073/pnas.1913212116.
|
|
Chalmers, AJ;
Chan, C;
Sebag-Montefiore, D;
Sebag-Montefiore, D;
Evans, M;
Chalmers, A;
McKenna, G;
... Chan, C; + view all
(2019)
CTRad 10 Years On: From 10-point Plan to Top 10 Achievements.
[Editorial comment].
Clinical Oncology
10.1016/j.clon.2019.09.043.
(In press).
|
|
Chambers, P;
Jani, Y;
Wei, L;
Kipps, E;
Forster, MD;
Wong, ICK;
(2019)
Patient Factors and their Impact on Neutropenic Events: A Systematic review and meta-analysis.
Supportive Care in Cancer
, 27
(7)
pp. 2413-2424.
10.1007/s00520-019-04773-6.
|
|
Chan, JKY;
Gil-Farina, I;
Johana, N;
Rosales, C;
Tan, YW;
Ceiler, J;
Mcintosh, J;
... Mattar, CNZ; + view all
(2019)
Therapeutic expression of human clotting factors IX and X following adeno-associated viral vector-mediated intrauterine gene transfer in early-gestation fetal macaques.
FASEB Journal
, 33
(3)
pp. 3954-3967.
10.1096/fj.201801391R.
|
|
|
Chan, TA;
Yarchoan, M;
Jaffee, E;
Swanton, C;
Quezada, SA;
Stenzinger, A;
Peters, S;
(2019)
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic.
Annals of Oncology
, 30
(1)
pp. 44-56.
10.1093/annonc/mdy495.
|
|
|
Chandy, E;
Taylor, H;
Gaito, S;
Wells, E;
Jones, C;
Meehan, C;
Burland, H;
... Mandeville, H; + view all
(2019)
Hypofractionated Stereotactic Ablative Radiotherapy for Recurrent or Oligometastatic Tumours in Children and Young Adults.
Clinical Oncology
10.1016/j.clon.2019.11.005.
(In press).
|
|
|
Chang, J-M;
Floden, EW;
Herrero, J;
Gascuel, O;
Di Tommaso, P;
Notredame, C;
(2019)
Incorporating alignment uncertainty into Felsenstein’s phylogenetic bootstrap to improve its reliability.
Bioinformatics
10.1093/bioinformatics/btz082.
(In press).
|
|
Chauhan, N;
Mulcahy, MF;
Salem, R;
Benson Iii, AB;
Boucher, E;
Bukovcan, J;
Cosgrove, D;
... Sharma, RA; + view all
(2019)
TheraSphere Yttrium-90 Glass Microspheres Combined With Chemotherapy Versus Chemotherapy Alone in Second-Line Treatment of Patients With Metastatic Colorectal Carcinoma of the Liver: Protocol for the EPOCH Phase 3 Randomized Clinical Trial.
JMIR Research Protocols
, 8
(1)
, Article e11545. 10.2196/11545.
|
|
Chavda, SJ;
Maciocia, PM;
Mesiri, P;
Counsell, N;
Kothari, J;
Bird, A;
Mariner, C;
... Yong, K; + view all
(2019)
A new prognostic model for myeloma patients relapsing from upfront autologous transplantation based on ISS and PFS1.
British Journal of Haematology
, 185
(2)
pp. 350-353.
10.1111/bjh.15487.
|
|
Chemaly, RF;
Hill, JA;
Voigt, S;
Peggs, KS;
(2019)
In vitro comparison of currently available and investigational antiviral agents against pathogenic human double-stranded DNA viruses: A systematic literature review.
Antiviral Research
, 163
pp. 50-58.
10.1016/j.antiviral.2019.01.008.
|
|
|
Chemi, F;
Rothwell, DG;
McGranahan, N;
Gulati, S;
Abbosh, C;
Pearce, SP;
Zhou, C;
... TRACERx Consortium, .; + view all
(2019)
Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse.
Nature Medicine
, 25
pp. 1534-1539.
10.1038/s41591-019-0593-1.
|
|
Chen, LY;
Keddie, S;
Lunn, MP;
Bomsztyk, J;
Vitsaras, E;
Gupta, R;
D'Sa, S;
(2019)
IgM paraprotein-associated peripheral neuropathy: small CD20-positive B-cell clones may predict a monoclonal gammopathy of neurological significance and rituximab responsiveness.
British Journal of Haematology
10.1111/bjh.16210.
(In press).
|
|
Chen, W;
Morabito, SJ;
Kessenbrock, K;
Enver, T;
Meyer, KB;
Teschendorff, AE;
(2019)
Single-cell landscape in mammary epithelium reveals bipotent-like cells associated with breast cancer risk and outcome.
Communications Biology
, 2
, Article 306. 10.1038/s42003-019-0554-8.
|
|
|
Chen, X;
Zhabyeyev, P;
Azad, AK;
Wang, W;
Minerath, RA;
DesAulniers, J;
Grueter, CE;
... Oudit, GY; + view all
(2019)
Endothelial and cardiomyocyte PI3Kβ divergently regulate cardiac remodelling in response to ischaemic injury.
Cardiovascular Research
, 115
(8)
pp. 1343-1356.
10.1093/cvr/cvy298.
|
|
Chervova, O;
Conde, L;
Guerra-Assunção, JA;
Moghul, I;
Webster, AP;
Berner, A;
Larose Cadieux, E;
... Beck, S; + view all
(2019)
The Personal Genome Project-UK, an open access resource of human multi-omics data.
Scientific Data
, 6
, Article 257. 10.1038/s41597-019-0205-4.
|
|
|
Childs, Alexa;
(2019)
The Molecular Characterisation of Circulating Tumour Cells in Neuroendocrine Neoplasms.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Christen, F;
Hoyer, K;
Yoshida, K;
Hou, H-A;
Waldhueter, N;
Heuser, M;
Hills, RK;
... Damm, F; + view all
(2019)
Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): an international study on 331 patients.
Blood
10.1182/blood-2018-05-852822.
(In press).
|
|
Chung, HC;
Arkenau, H-T;
Lee, J;
Rha, SY;
Oh, D-Y;
Wyrwicz, L;
Kang, Y-K;
... Safran, H; + view all
(2019)
Avelumab (anti-PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gastric or gastroesophageal junction cancer: phase 1b results from the JAVELIN Solid Tumor trial.
Journal for ImmunoTherapy of Cancer
, 7
, Article 30. 10.1186/s40425-019-0508-1.
|
|
|
Clamp, AR;
James, EC;
McNeish, IA;
Dean, A;
Kim, J-W;
O'Donnell, DM;
Hook, J;
... Ledermann, JA; + view all
(2019)
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial.
The Lancet
10.1016/s0140-6736(19)32259-7.
|
|
|
Clarke, MA;
Fisher, J;
(2019)
Prognostic hallmarks in AML.
Nature Biomedical Engineering
, 3
(11)
pp. 847-849.
10.1038/s41551-019-0474-4.
|
|
Clarke, NW;
Ali, A;
Ingleby, FC;
Hoyle, A;
Amos, CL;
Attard, G;
Brawley, CD;
... James, ND; + view all
(2019)
Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial.
Annals of Oncology
10.1093/annonc/mdz396.
(In press).
|
|
Cohen, OC;
Counsell, N;
Rabin, N;
Popat, R;
Owen, RG;
Popova, B;
Schofield, O;
... Yong, KL; + view all
(2019)
Bortezomib consolidation post-ASCT as frontline therapy for multiple myeloma deepens disease response and MRD-negative rate whilst maintaining QOL and response to re-treatment at relapse.
[Letter].
British Journal of Haematology
, 185
(5)
pp. 948-951.
10.1111/bjh.15649.
|
|
Colombo, N;
Sessa, C;
du Bois, A;
Ledermann, J;
McCluggage, WG;
McNeish, I;
Morice, P;
... Zeimet, AG; + view all
(2019)
ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease.
International Journal of Gynecological Cancer
, 29
(4)
pp. 728-760.
10.1136/ijgc-2019-000308.
|
|
|
Colombo, N;
Sessa, C;
du Bois, A;
Ledermann, J;
McCluggage, WG;
McNeish, I;
Morice, P;
... ESMO–ESGO Ovarian Cancer Consensus Conference Working Group, .; + view all
(2019)
ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease.
Annals of Oncology
, 30
(5)
pp. 672-705.
10.1093/annonc/mdz062.
|
|
Conduit, SE;
Davies, EM;
Ooms, LM;
Gurung, R;
McGrath, MJ;
Hakim, S;
Cottle, DL;
... Mitchell, CA; + view all
(2019)
AKT signaling promotes DNA damage accumulation and proliferation in polycystic kidney disease.
Human Molecular Genetics
10.1093/hmg/ddz232.
(In press).
|
|
Conesa, A;
Beck, S;
(2019)
Making multi-omics data accessible to researchers.
[Editorial comment].
Scientific Data
, 6
(1)
, Article 251. 10.1038/s41597-019-0258-4.
|
|
|
Conteduca, V;
Jayaram, A;
Romero-Laorden, N;
Wetterskog, D;
Salvi, S;
Gurioli, G;
Scarpi, E;
... de Giorgi, U; + view all
(2019)
Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer.
European Urology
10.1016/j.eururo.2018.09.049.
(In press).
|
|
|
Cook, G;
Royle, K-L;
O'Connor, S;
Cairns, DA;
Ashcroft, AJ;
Williams, CD;
Hockaday, A;
... National Cancer Research Institute Haemato-oncology Clinical Stu, ; + view all
(2019)
The impact of cytogenetics on duration of response and overall survival in patients with relapsed multiple myeloma (long-term follow-up results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial.
British Journal of Haematology
10.1111/bjh.15782.
(In press).
|
|
|
Coombes, C;
Page, K;
Salari, R;
Hastings, RK;
Armstrong, AC;
Ahmed, S;
Ali, S;
... Shaw, JA; + view all
(2019)
Personalized detection of circulating tumor DNA antedates breast cancer metastatic recurrence.
Clinical Cancer Research
10.1158/1078-0432.CCR-18-3663.
(In press).
|
|
Coosemans, A;
Vankerckhoven, A;
Baert, T;
Boon, L;
Ruts, H;
Riva, M;
Blagden, S;
... Vergote, I; + view all
(2019)
Combining conventional therapy with immunotherapy: A risky business?
European Journal of Cancer
, 113
pp. 41-44.
10.1016/j.ejca.2019.02.014.
|
|
Coughtrey, AE;
Shafran, R;
Su, MT;
Allcott-Watson, H;
Christie, D;
Hough, R;
(2019)
Health Professionals' Perspectives on the Nature of Distress and Low Mood in Young People with Cancer.
Journal of Adolescent and Young Adult Oncology
, 8
(2)
pp. 190-196.
10.1089/jayao.2018.0082.
|
|
Creary, LE;
Guerra, SG;
Chong, W;
Brown, CJ;
Turner, TR;
Robinson, J;
Bultitude, WP;
... Fernandez-Vina, MA; + view all
(2019)
Next-generation HLA typing of 382 International Histocompatibility Working Group reference B-lymphoblastoid cell lines: Report from the 17th International HLA and Immunogenetics Workshop.
Human Immunology
, 80
(7)
pp. 449-460.
10.1016/j.humimm.2019.03.001.
|
|
Crowley, C;
Butler, C;
Camilli, C;
Hynds, R;
Kolluri, KK;
Janes, SM;
De Coppi, P;
(2019)
Non-invasive longitudinal bioluminescence imaging of human mesoangioblasts in bioengineered esophagi.
Tissue Engineering Part C: Methods
, 25
(2)
pp. 103-113.
10.1089/ten.TEC.2018.0351.
|
|
|
Cuadrado, MM;
Szydlo, RM;
Watts, M;
Patel, N;
Renshaw, H;
Dorman, J;
Lowdell, M;
... Chakraverty, R; + view all
(2019)
Predictors of recovery following allogeneic CD34+-selected cell infusion without conditioning to correct poor graft function.
Haematologica
10.3324/haematol.2019.226340.
(In press).
|
|
Cuff, AO;
Sillito, F;
Dertschnig, S;
Hall, A;
Tu, VL;
Chakraverty, R;
Male, V;
(2019)
The Obese Liver Environment Mediates Conversion of NK Cells to a Less Cytotoxic ILC1-Like Phenotype.
Frontiers in Immunology
, 10
, Article 2180. 10.3389/fimmu.2019.02180.
|
|
D
|
Dagil, L;
Troelsen, KS;
Bolt, G;
Thim, L;
Wu, B;
Zhao, X;
Tuddenham, EGD;
... Hansen, DF; + view all
(2019)
Interaction Between the a3 Region of Factor VIII and the TIL'E’ Domains of the von Willebrand Factor.
Biophysical Journal
, 117
(3)
pp. 479-489.
10.1016/j.bpj.2019.07.007.
|
|
|
Das-Gupta, E;
Thomson, KJ;
Bloor, AJC;
Clark, AD;
Mackinnon, S;
Kayani, I;
Clifton-Hadley, L;
... Peggs, KS; + view all
(2019)
Allo-HSCT in transplant-naive patients with Hodgkin lymphoma: a single-arm, multicenter study.
Blood Advances
, 3
(24)
pp. 4264-4270.
10.1182/bloodadvances.2019001016.
|
|
Dehbi, H-M;
Mallick, U;
Wadsley, J;
Newbold, K;
Harmer, C;
Hackshaw, A;
(2019)
Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial.
Lancet Diabetes and Endocrinology
, 7
(1)
pp. 44-51.
10.1016/S2213-8587(18)30306-1.
|
|
|
Deiss, K;
Lockwood, N;
Howell, M;
Segeren, HA;
Saunders, RE;
Chakravarty, P;
Soliman, TN;
... Parker, PJ; + view all
(2019)
A genome-wide RNAi screen identifies the SMC5/6 complex as a non-redundant regulator of a Topo2a-dependent G2 arrest.
Nucleic Acids Research
, 47
(6)
pp. 2906-2921.
10.1093/nar/gky1295.
|
|
|
Dillon, MT;
Grove, L;
Newbold, KL;
Shaw, H;
Brown, NF;
Mendell, J;
Chen, S;
... Harrington, KJ; + view all
(2019)
Patritumab with Cetuximab plus Platinum-Containing Therapy in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: An Open-Label, Phase Ib Study.
Clinical Cancer Research
, 25
(2)
pp. 487-495.
10.1158/1078-0432.CCR-18-1539.
|
|
Dodagatta-Marri, E;
Meyer, DS;
Reeves, MQ;
Paniagua, R;
To, MD;
Binnewies, M;
Broz, ML;
... Akhurst, RJ; + view all
(2019)
α-PD-1 therapy elevates Treg/Th balance and increases tumor cell pSmad3 that are both targeted by α-TGFβ antibody to promote durable rejection and immunity in squamous cell carcinomas.
Journal for ImmunoTherapy of Cancer
, 7
, Article 62. 10.1186/s40425-018-0493-9.
|
|
|
Donald, A;
Cizer, H;
Finnegan, N;
Collin-Histed, T;
Hughes, DA;
Davies, EH;
(2019)
Measuring disease activity and patient experience remotely using wearable technology and a mobile phone app: outcomes from a pilot study in Gaucher disease.
Orphanet Journal of Rare Diseases
, 14
, Article 212. 10.1186/s13023-019-1182-6.
|
|
|
Drew, Y;
Kristeleit, RS;
Oaknin, A;
Ray-Coquard, I;
Haris, NM;
Swisher, EM;
(2019)
Real-World Delivery of Rucaparib to Patients with Ovarian Cancer: Recommendations Based on an Integrated Safety Analysis of ARIEL2 and Study 10.
The Oncologist
10.1634/theoncologist.2019-0229.
(In press).
|
|
|
Dyke, SOM;
Saulnier, KM;
Dupras, C;
Webster, AP;
Maschke, K;
Rothstein, M;
Siebert, R;
... Joly, Y; + view all
(2019)
Points-to-consider on the return of results in epigenetic research.
Genome Medicine
, 11
(1)
, Article 31. 10.1186/s13073-019-0646-6.
|
|
|
de Boer, SM;
Powell, ME;
Mileshkin, L;
Katsaros, D;
Bessette, P;
Haie-Meder, C;
Ottevanger, PB;
... Tubiana-Mathieu, N; + view all
(2019)
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial.
The Lancet Oncology
10.1016/S1470-2045(19)30395-X.
(In press).
|
|
|
de Bono, JS;
Concin, N;
Hong, DS;
Thistlethwaite, FC;
Machiels, J-P;
Arkenau, H-T;
Plummer, R;
... Lassen, U; + view all
(2019)
Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1-2 trial.
Lancet Oncology
, 20
(3)
pp. 383-393.
10.1016/S1470-2045(18)30859-3.
|
E
|
Ecker, S;
Beck, S;
(2019)
The epigenetic clock: a molecular crystal ball for human aging?
Aging (Albany NY)
, 11
(2)
pp. 833-835.
10.18632/aging/101712.
|
|
|
Efthymiou, M;
Mackie, IJ;
Lane, PJ;
Andrade, D;
Willis, R;
Erkan, D;
Sciascia, S;
... APS ACTION, .; + view all
(2019)
Comparison of Real World and Core Laboratory Lupus Anticoagulant Results from the Antiphospholipid Syndrome (APS) ACTION Clinical Database and Repository.
Journal of Thrombosis and Haemostasis
10.1111/jth.14596.
(In press).
|
|
El-Sharkawi, D;
Ng, C-H;
Payne, EMC;
Yong, KL;
Ardeshna, KM;
Khwaja, A;
Townsend, W;
(2019)
Clinical outcomes and survival of patients with myeloma and lymphoma enrolled into phase I clinical trials.
British Journal of Haematology
, 185
(2)
pp. 344-347.
10.1111/bjh.15457.
|
|
Embleton-Thirsk, A;
Deane, E;
Townsend, S;
Farrelly, L;
Popoola, B;
Parker, J;
Rustin, G;
... Kaplan, R; + view all
(2019)
Impact of retrospective data verification to prepare the ICON6 trial for use in a marketing authorization application.
Clinical Trials
, 16
(5)
pp. 502-511.
10.1177/1740774519862528.
|
|
|
Evans, R;
Flores-Borja, F;
Nassiri, S;
Miranda, E;
Lawler, K;
Grigoriadis, A;
Monypenny, J;
... Ng, T; + view all
(2019)
Integrin-Mediated Macrophage Adhesion Promotes Lymphovascular Dissemination in Breast Cancer.
Cell Reports
, 27
(7)
1967-1978.e4.
10.1016/j.celrep.2019.04.076.
|
|
|
Evans, RDR;
Cargill, T;
Goodchild, G;
Oliveira, B;
Rodriguez-Justo, M;
Pepper, R;
Connolly, J;
... Culver, EL; + view all
(2019)
Clinical Manifestations and Long-term Outcomes of IgG4-Related Kidney and Retroperitoneal Involvement in a United Kingdom IgG4-Related Disease Cohort.
Kidney International Reports
, 4
(1)
pp. 48-58.
10.1016/j.ekir.2018.08.011.
|
|
|
Evans, REC;
Taylor, SA;
Kalasthry, J;
Sakai, NS;
Miles, A;
Streamline investigators, ;
(2019)
Patient deprivation and perceived scan burden negatively impact the quality of whole-body MRI.
Clinical Radiology
10.1016/j.crad.2019.10.019.
(In press).
|
|
|
Evans, TRJ;
Dean, E;
Molife, LR;
Lopez, J;
Ranson, M;
El-Khouly, F;
Zubairi, I;
... Kristeleit, R; + view all
(2019)
Phase 1 dose-finding and pharmacokinetic study of eribulin-liposomal formulation in patients with solid tumours.
British Journal of Cancer
, 120
pp. 379-386.
10.1038/s41416-019-0377-x.
|
|
|
Eyre, TA;
Kirkwood, AA;
Gohill, S;
Follows, G;
Walewska, R;
Walter, H;
Cross, M;
... the UK CLL Forum, ; + view all
(2019)
Efficacy of venetoclax monotherapy in patients with relapsed chronic lymphocytic leukaemia in the post-BCR inhibitor setting: a UK wide analysis.
British Journal of Haematology
, 185
(4)
pp. 656-669.
10.1111/bjh.15802.
|
F
|
Fang, C;
Virdee, S;
Jacob, J;
Rufai, O;
Agarwal, K;
Quaglia, A;
Quinlan, DJ;
(2019)
Strain elastography for noninvasive assessment of liver fibrosis: A prospective study with histological comparison.
Ultrasound
10.1177/1742271X19862836.
(In press).
|
|
|
Ferrer, IR;
West, HC;
Henderson, S;
Ushakov, DS;
Santos E Sousa, P;
Strid, J;
Chakraverty, R;
... Bennett, CL; + view all
(2019)
A wave of monocytes is recruited to replenish the long-term Langerhans cell network after immune injury.
Science Immunology
, 4
(38)
, Article eaax8704. 10.1126/sciimmunol.aax8704.
|
|
|
Fielding, AK;
(2019)
Curing Ph+ ALL: assessing the relative contributions of chemotherapy, TKIs, and allogeneic stem cell transplant.
Hematology, the ASH Education Program
, 2019
(1)
pp. 24-29.
10.1182/hematology.2019000010.
|
|
Fielding, AK;
(2019)
En-Abl-ing treatment of “Ph-like” ALL?
Blood
, 134
(16)
pp. 1277-1278.
10.1182/blood.2019002621.
|
|
Fittall, MW;
Van Loo, P;
(2019)
Translating insights into tumor evolution to clinical practice: promises and challenges.
Genome Medicine
, 11
, Article 20. 10.1186/s13073-019-0632-z.
|
|
Forster, MD;
Dillon, MT;
Kocsis, J;
Remenár, É;
Pajkos, G;
Rolland, F;
Greenberg, J;
(2019)
Patritumab or placebo, with cetuximab plus platinum therapy in recurrent or metastatic squamous cell carcinoma of the head and neck: A randomised phase II study.
European Journal of Cancer
, 123
pp. 36-47.
10.1016/j.ejca.2019.08.017.
|
|
|
Fox, TA;
Halsey, R;
Pomplun, S;
Gant, V;
Grandage, V;
Mansour, MR;
Hough, R;
(2019)
Rapid clinical response to adjuvant corticosteroids in chronic disseminated candidiasis complicated by granulomas and persistent fever in acute leukemia patients.
[Letter].
Leukemia & Lymphoma
10.1080/10428194.2019.1691198.
(In press).
|
|
Foxall, E;
Staszowska, A;
Hirvonen, LM;
Georgouli, M;
Ciccioli, M;
Rimmer, A;
Williams, L;
... Wells, CM; + view all
(2019)
PAK4 Kinase Activity Plays a Crucial Role in the Podosome Ring of Myeloid Cells.
Cell Reports
, 29
(11)
3385-3393.e6.
10.1016/j.celrep.2019.11.016.
|
|
|
Franz Demane, Dafne Sofia;
(2019)
Defining and targeting combination immunotherapies in mouse models of cancer.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Frizziero, M;
Wang, X;
Chakrabarty, B;
Childs, A;
Luong, TV;
Walter, T;
Khan, MS;
... McNamara, MG; + view all
(2019)
Retrospective study on mixed neuroendocrine non-neuroendocrine neoplasms from five European centres.
World Journal of Gastroenterology
, 25
(39)
pp. 5991-6005.
10.3748/wjg.v25.i39.5991.
|
|
|
Fujimitsu, K;
Yamano, H;
(2019)
PP2A-B56 binds to Apc1 and promotes Cdc20 association with the APC/C ubiquitin ligase in mitosis.
EMBO Reports
, Article e48503. 10.15252/embr.201948503.
(In press).
|
|
|
Furniss, D;
Mayer, A;
Franklin, BD;
Blandford, A;
(2019)
Exploring structure, agency and performance variability in everyday safety: An ethnographic study of practices around infusion devices using distributed cognition.
Safety Science
, 118
pp. 687-701.
10.1016/j.ssci.2019.06.006.
|
|
G
|
Gaifulina, R;
Caruana, DJ;
Oukrif, D;
Guppy, NJ;
Culley, S;
Brown, R;
Bell, I;
... Thomas, GMH; + view all
(2019)
Rapid and complete paraffin removal from human tissue sections delivers enhanced Raman spectroscopic and histopathological analysis.
Analyst
10.1039/c9an01030k.
(In press).
|
|
|
Germain, DP;
Arad, M;
Burlina, A;
Elliott, PM;
Falissard, B;
Feldt-Rasmussen, U;
Hilz, MJ;
... Spada, M; + view all
(2019)
The effect of enzyme replacement therapy on clinical outcomes in female patients with Fabry disease - A systematic literature review by a European panel of experts.
Molecular Genetics and Metabolism
, 126
(3)
pp. 224-235.
10.1016/j.ymgme.2018.09.007.
|
|
|
Germain, DP;
Nicholls, K;
Giugliani, R;
Bichet, DG;
Hughes, DA;
Barisoni, LM;
Colvin, RB;
... Viereck, C; + view all
(2019)
Efficacy of the pharmacologic chaperone migalastat in a subset of male patients with the classic phenotype of Fabry disease and migalastat-amenable variants: data from the phase 3 randomized, multicenter, double-blind clinical trial and extension study.
Genetics in Medicine
10.1038/s41436-019-0451-z.
(In press).
|
|
|
Gewandter, JS;
Dworkin, RH;
Turk, DC;
Devine, EG;
Hewitt, D;
Jensen, MP;
Katz, NP;
... Witter, J; + view all
(2019)
Improving study conduct and data quality in clinical trials of chronic pain treatments: IMMPACT recommendations.
The Journal of Pain
10.1016/j.jpain.2019.12.003.
(In press).
|
|
Ghorashian, S;
Kramer, AM;
Onuoha, S;
Wright, G;
Bartram, J;
Richardson, R;
Albon, SJ;
... Amrolia, PJ; + view all
(2019)
Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR.
Nature Medicine
, 25
pp. 1408-1414.
10.1038/s41591-019-0549-5.
|
|
Gjini, E;
Jing, C-B;
Nguyen, AT;
Reyon, D;
Gans, E;
Kesarsing, M;
Peterson, J;
... Look, AT; + view all
(2019)
Disruption of asxl1 results in myeloproliferative neoplasms in zebrafish.
Disease Models & Mechanisms
, 12
(5)
, Article dmm035790. 10.1242/dmm.035790.
|
|
|
Glaire, MA;
Domingo, E;
Sveen, A;
Bruun, J;
Nesbakken, A;
Nicholson, G;
Novelli, M;
... Church, DN; + view all
(2019)
Tumour-infiltrating CD8^{+} lymphocytes and colorectal cancer recurrence by tumour and nodal stage.
British Journal of Cancer
10.1038/s41416-019-0540-4.
(In press).
|
|
|
Glaser, M;
Rajkumar, V;
Diocou, S;
Gendron, T;
Yan, R;
Sin, PKB;
Sander, K;
... Arstad, E; + view all
(2019)
One-Pot Radiosynthesis and Biological Evaluation of a Caspase-3 Selective 5-[¹²³,¹²⁵I]iodo-1,2,3-triazole derived Isatin SPECT Tracer.
Scientific Reports
, 9
, Article 19299. 10.1038/s41598-019-55992-0.
|
|
|
Golan, T;
Hammel, P;
Reni, M;
Van Cutsem, E;
Macarulla, T;
Hall, MJ;
Park, J-O;
... Kindler, HL; + view all
(2019)
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer.
The New England Journal of Medicine
, 381
pp. 317-327.
10.1056/NEJMoa1903387.
|
|
Gollmann-Tepeköylü, C;
Pölzl, L;
Graber, M;
Hirsch, J;
Nägele, F;
Lobenwein, D;
Hess, MW;
... Holfeld, J; + view all
(2019)
miR-19a-3p containing exosomes improve function of ischemic myocardium upon shock wave therapy.
Cardiovascular Research
10.1093/cvr/cvz209.
(In press).
|
|
González Martín, A;
Oza, A;
Embleton, AC;
Pfisterer, J;
Ledermann, J;
Pujade-Lauraine, E;
Kristensen, G;
... Perren, T; + view all
(2019)
Exploratory outcome analyses according to stage and/or residual disease in the ICON7 trial of carboplatin and paclitaxel with or without bevacizumab for newly diagnosed ovarian cancer.
Gynecologic Oncology
, 152
(1)
10.1016/j.ygyno.2018.08.036.
|
|
|
González-Billalabeitia, E;
Conteduca, V;
Wetterskog, D;
Jayaram, A;
Attard, G;
(2019)
Circulating tumor DNA in advanced prostate cancer: transitioning from discovery to a clinically implemented test.
Prostate Cancer and Prostatic Diseases
, 22
pp. 195-205.
10.1038/s41391-018-0098-x.
|
|
Gore, M;
Hackshaw, A;
Brady, WE;
Penson, RT;
Zaino, R;
McCluggage, WG;
Ganesan, R;
... Gershenson, DM; + view all
(2019)
An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumor.
Gynecologic Oncology
10.1016/j.ygyno.2019.03.256.
(In press).
|
|
|
Goswami, P;
Oliva, EN;
Ionova, T;
Else, R;
Kell, J;
Fielding, AK;
Jennings, DM;
... Salek, S; + view all
(2019)
Paper and electronic versions of HM-PRO, a novel patient-reported outcome measure for hematology: an equivalence study.
Journal Of Comparative Effectiveness Research
, 8
(7)
pp. 523-533.
10.2217/cer-2018-0108.
|
|
| Gourley, C; Balmaña, J; Ledermann, JA; Serra, V; Dent, R; Loibl, S; Pujade-Lauraine, E; |